3.03
Schlusskurs vom Vortag:
$3.15
Offen:
$3.15
24-Stunden-Volumen:
88,790
Relative Volume:
0.72
Marktkapitalisierung:
$127.64M
Einnahmen:
$52.84M
Nettoeinkommen (Verlust:
$-11.11M
KGV:
-11.05
EPS:
-0.2742
Netto-Cashflow:
$-9.12M
1W Leistung:
-0.33%
1M Leistung:
-25.55%
6M Leistung:
-19.84%
1J Leistung:
+49.26%
Apyx Medical Corp Stock (APYX) Company Profile
Firmenname
Apyx Medical Corp
Sektor
Branche
Telefon
(727) 384-2323
Adresse
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
APYX
Apyx Medical Corp
|
3.03 | 132.69M | 52.84M | -11.11M | -9.12M | -0.2742 |
|
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-12-16 | Eingeleitet | Roth Capital | Buy |
| 2025-11-14 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-11-12 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-10-17 | Eingeleitet | BTIG Research | Neutral |
| 2023-07-14 | Eingeleitet | Stephens | Overweight |
| 2022-05-20 | Eingeleitet | Lake Street | Buy |
| 2019-04-02 | Bestätigt | Dougherty & Company | Buy |
Alle ansehen
Apyx Medical Corp Aktie (APYX) Neueste Nachrichten
Apyx Medical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring - MarketBeat
Apyx Medical at Canaccord Genuity: bets on surgical aesthetics By Investing.com - Investing.com India
Apyx Medical at Canaccord Genuity: bets on surgical aesthetics - Investing.com
HC Wainwright Predicts Weaker Earnings for Apyx Medical - MarketBeat
Apyx Medical Corp (BOV.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Sei Investments Co. Buys 448,174 Shares of Apyx Medical Corporation $APYX - MarketBeat
Apyx Medical Corporation (NASDAQ:APYX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Apyx Medical (NASDAQ:APYX) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS - marketbeat.com
Apyx Medical Corp (APYX) Stock News Today - TradingKey
Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Earnings call transcript: Apyx Medical tops Q2 2026 estimates, shares slip after hours - Investing.com South Africa
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ... - Yahoo Finance UK
Apyx Medical Q2 Earnings Call Highlights - MarketBeat
Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Apyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary - TradingView
Apyx Medical Corp. R (BOV.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Apyx Medical Reports Q2 2026 Revenue of $13.9M, Surgical Aesthetics Up 28% - TradingView
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results - Yahoo Finance
APYX|Apyx Medical Corp|Price:4.179|Chg%:+0.079 - tradingkey.com
Apyx Medical CEO and CFO to Hold Aug. 11 Investor Fireside Chat - Stock Titan
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apyx Medical Corp (APYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
APYX|Apyx Medical Corp|Price:3.850|Chg%:-0.070 - TradingKey
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apyx Medical Corp (APYX) Balance Sheet - TradingKey
APYX|Apyx Medical Corp|Price:4.290|Chg%:+0.110 - TradingKey
Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
APYX|Apyx Medical Corp|Price:4.140| - TradingKey
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout | AI
Apyx Medical Corporation Reconstitutes Board Committees – SEC 8-K Filing Details, July 24, 2026 - Minichart
Apyx Medical Corp (APYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apyx Medical Schedules Live Q&A on Second-Quarter Results Aug. 6 - Stock Titan
Royce & Associates (APYX) reports 3.27M Apyx Medical shares under Schedule 13G/A - Stock Titan
HC Wainwright Comments on Apyx Medical Q2 Earnings - MarketBeat
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
APYX Initiates Coverage On by HC Wainwright & Co. -- Price Targe - GuruFocus
Apyx Medical (APYX) director nets 6,976 shares from 12,000-option exercise and share withholding - Stock Titan
APYXApyx Medical Corp Volatility & Greeks - Finviz
APYX | Apyx Medical Corporation Common Executive Compensation - Quiver Quantitative
Apyx Medical (NASDAQ: APYX) details 2026 votes on directors, pay and new incentive plan - Stock Titan
Apyx Medical Corp (APYX) Institutional Confidence - TradingKey
Form DEF 14A Apyx Medical Inc For: 23 June By Investing.com - Investing.com Australia
Apyx Medical Shares Rise on Promising Cellulite Treatment DataDividend Increase Stocks - dars.gov.et
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity - Insider Monkey
Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Finanzdaten der Apyx Medical Corp-Aktie (APYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):